Schools

Details

• Alternative Title:
  J Allergy Clin Immunol Pract
• Personal Author:
  Howard, Evin J. ; Vesper, Stephen J. ; Guthrie, Barbara J. ; Petty, Carter R. ; Ramdin, Valeria A. ; Sheehan, William J. ; Gaffin, Jonathan M. ; Permaul, Perdita ; Lai, Peggy S. ; Bartnikas, Lisa M. ; Cunningham, Amparito ; Hauptman, Marissa ; Gold, Diane R. ; Baxi, Sachin N. ; Phipatanakul, Wanda
• Description:
  Background:
  
  Asthma is among the most common chronic diseases of children in the United States (US). Mold exposures have been linked to asthma development and exacerbation. In homes, mold exposures have been quantified using the Environmental Relative Moldiness Index (ERMI) and higher home ERMI values have been linked to occupant asthma.
  
  Objective:
  
  In this analysis of the School Inner-City Asthma Study (SICAS), we aimed to evaluate the ERMI’s applicability to measuring mold in schools compared with home mold levels, and to examine the prevalence of asthma in relationship to students’ demographics and the physical characteristics of school-buildings.
  
  Methods:
  
  Northeastern US schools (n=32) and homes (n=33) were selected and the 36-ERMI molds were quantified in a dust sample from each classroom (n=114) or home. School building characteristics were collected from SICAS. Asthma prevalence and student demographics data were obtained from government websites.
  
  Results:
  
  Levels of outdoor Group 2 molds were significantly (p<0.01) greater in schools compared with homes. The presence of air-conditioning in school buildings correlated significantly (P =0.02) with lower asthma prevalence.
  
  Conclusion:
  
  The prevalence of asthma in student bodies is associated with many factors in schools and homes.
  
  
• Subjects:
  Air Pollution, Indoor Article Asthma Child ERMI Fungi Homes Housing Humans Mold Northeast Prevalence Schools United States

  More +
• Source:
  J Allergy Clin Immunol Pract. 9(3):1312-1318
• Pubmed ID:
  33091637
• Pubmed Central ID:
  PMC7946701
• Document Type:
  Journal Article
• Funding:
  U01 AI110397/AI/NIAID NIH HHSUnited States/ ; K23 AI104780/AI/NIAID NIH HHSUnited States/ ; K23 AI123517/AI/NIAID NIH HHSUnited States/ ; K23 AI143962/AI/NIAID NIH HHSUnited States/ ; R01TS000296/ACL/ACL HHSUnited States/ ; R01 AI144119/AI/NIAID NIH HHSUnited States/ ; R01 TS000296/TS/ATSDR CDC HHSUnited States/ ; K24 AI106822/AI/NIAID NIH HHSUnited States/ ; R01 AI073964/AI/NIAID NIH HHSUnited States/ ; R01 HL137192/HL/NHLBI NIH HHSUnited States/ ; R01 ES030100/ES/NIEHS NIH HHSUnited States/ ; U10 HL098102/HL/NHLBI NIH HHSUnited States/
• Volume:
  9
• Issue:
  3
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:d7e98ab2c6da105e52845c80b4da61f6ebc646edd222537bb38dc6d71e69c2a8
• Download URL:
  https://stacks.cdc.gov/view/cdc/104093/cdc_104093_DS1.pdf
• File Type:
  [PDF - 129.91 KB ]